Site-Specific Cleavage of RNA and DNA by Complementary DNA-Bleomycin A5 Conjugates

Bioconjugate Chemistry

Volumn 14, Issue 6, 2003, Pages 1307-1313

  Vorobjev, Pavel E ^a   Smith, Janet B ^b   Pyshnaya, Inna A ^a   Levina, Asya S ^a   Zarytova, Valentina F ^a   Wickstrom, Eric ^c  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IRON COMPOUNDS; LITHIUM COMPOUNDS; OLIGONUCLEOTIDES; PEPTIDES;

BASE PAIRS; BLEOMYCINS; CHEMOTHERAPEUTIC ACTIVITY; DNA TARGETS; LOW MOBILITY; MISMATCH CONTROL; OLIGODEOXYNUCLEOTIDES; SITE-SPECIFIC; SPECIFIC CLEAVAGES; SPECIFIC SITES;

RNA;

BLEOMYCIN A5;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; CHEMICAL REACTION; CONJUGATION; DNA CLEAVAGE; ELECTROPHORETIC MOBILITY; GENE SEQUENCE; GENE TARGETING; HYBRIDIZATION; RNA CLEAVAGE;

EID: 0345357002     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034148u     Document Type: Article

References (20)

1. Belikova, A. M., Zarytova, V. F., and Grineva, N. I. (1967) Tetrahedron Lett. 37, 3557-62.
2. Zamecnik, P. C., and Stephenson, M. L. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 280-4.
3. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H., and Wickstrom, E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1028-32.
4. Wickstrom, E. (1991) Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS, Wiley-Liss, New York.
5. Agrawal, S. (1996) Antisense Therapeutics, Humana Press, Totowa, NJ.
6. Wickstrom, E. (1998) Clinical Trials of Genetic Therapy with Antisense DNA and DNA Vectors, Marcel Dekker, New York.
7. Knorre, D. G., Vlassov, V. V., Zarytova, V. F., Lebedev, A. V., and Fedorova, O. S. (1994) Design and Targeted Reactions of Oligonucleotide Derivatives, CRC Press, Boca Raton, FL.
8. Sergeyev, D. S., and Zarytova, V. F. (1996) Russian Chemical Reviews 65, 355-378.
9. Umezawa, H. (1976) Prog. Biochem. Pharmacol. 11, 18-27.
10. Keck, M. V., and Hecht, S. M. (1995) Biochemistry 34, 12029-37.
11. Holmes, C. E., and Hecht, S. M. (1993) J. Biol. Chem. 268, 25909-13.
12. Smith, J. B., and Wickstrom, E. (1998) J. Natl. Cancer Inst. 90, 1146-54.
13. Gryaznov, S., Skorski, T., Cucco, C., Nieborowska-Skorska, M., Chiu, C. Y., Lloyd, D., Chen, J. K., Koziolkiewicz, M., and Calabretta, B. (1996) Nucleic Acids Res. 24, 1508-14.
14. Gazin, C., Dupont de Dinechin, S., Hampe, A., Masson, J. M., Martin, P., Stehelin, D., and Galibert, F. (1984) EMBO J. 3, 383-7.
15. Pyshnaya, I. A., Pyshnyi, D. V., Ivanova, E. M., Zarytova, V. F., Bonora, G. M., Scalfi-Happ, C., and Seliger, H. (1998) Nucleosides Nucleotides 17, 1289-1297.
16. Zarytova, V. F., Sergeyev, D. S., and Godovikova, T. S. (1993) Bioconjugate Chem. 4, 189-93.
17. Sergeyev, D. S., Godovikova, T. S., and Zarytova, V. F. (1995) Nucleic Acids Res. 23, 4400-6.
18. Gavin, I. M., Melnik, S. M., Yurina, N. P., Khabarova, M. I., and Bavykin, S. G. (1998) Anal. Biochem. 263, 26-30.
19. Sergeyev, D. S., Vorobjev, P. E., and Zarytova, V. F. (1997) Nucleosides Nucleotides 16, 1575-1577.
20. Berkner, K. L., and Folk, W. R. (1977) J. Biol. Chem. 252, 3176-84.